Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholder's Deficit (Unaudited)

v3.22.1
Condensed Consolidated Statements of Changes in Stockholder's Deficit (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning Balance at Dec. 31, 2020 $ 24,474 $ 690 $ 24,310 $ (526)
Balance, shares at Dec. 31, 2020   6,900,000    
Proceeds allocated to Private Placement Warrants 7,270,000   7,270,000  
Subsequent remeasurement under ASC 480-10-S99 (15,816,086)   $ (7,294,310) (8,521,776)
Net income (49,954)     (49,954)
Ending Balance at Mar. 31, 2021 (8,571,566) $ 690   (8,572,256)
Balance, shares at Mar. 31, 2021   6,900,000    
Beginning Balance at Dec. 31, 2021 (17,169,798) $ 690   (17,170,488)
Balance, shares at Dec. 31, 2021   6,900,000    
Net income 1,217,736     1,217,736
Ending Balance at Mar. 31, 2022 $ (15,952,062) $ 690   $ (15,952,752)
Balance, shares at Mar. 31, 2022   6,900,000